Author:
Xiao Zhen,Zhou Zhihui,Chu Cilong,Zhang Qian,Zhou Lingjia,Yang Zunhua,Li Xin,Yu Liying,Zheng Pengwu,Xu Shan,Zhu Wufu
Funder
The National Natural Science
Natural Science Foundation of Jiangxi, China
Education Department of Jiangxi Province
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference24 articles.
1. Cancer statistics;Siegel;Ca - Cancer J. Clin.,2016
2. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival;Fontanini;Clin. Canc. Res.,1998
3. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): simple drugs with a complex mechanism of action?;Normanno;J. Cell. Physiol.,2003
4. ERBB receptors and cancer: the complexity of targeted inhibitors;Hynes;Nat. Rev. Canc.,2005
5. Studies leading to the identification of ZD1839 (Iressa™): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer;Barker;Bioorg. Med. Chem. Lett,2001
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献